Anatara Lifesciences Ltd has released a press release.
Zoetis Exclusive Research Evaluation and License Option
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
Later from Anatara Lifesciences
- Milestone and Market Update
- Anatara Trial Update
- Anatara Expands Executive Team
- Successful Completion of Target Safety Study
- APVMA Submission Major Milestone Achieved
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences